Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients

Katsumichi Fujimaki, Takehiko Mori, Aiko Kida, Masatsugu Tanaka, Nobutaka Kawai, Takafumi Matsushima, Kenji Kishi, Shin Fujisawa, Tohru Sakura, Akira Yokota, Yoshinobu Kanda, Jun Taguchi, Hideki Akiyama, Heiwa Kanamori, Atsuo Maruta, Shinichiro Okamoto, Hisashi Sakamaki

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

We retrospectively investigated the clinical characteristics of human herpesvirus 6 (HHV-6) meningoencephalitis within 100 days after allogeneic hematopoietic stem cell transplantation (HSCT). Of 1148 patients who received transplants between January 1999 and December 2003, 11 patients (0.96%) with HHV-6 meningoencephalitis were identified. Ten of 11 recipients received hematopoietic stem cells from donors other than HLA-identical siblings. Confusion was the most frequent central nervous system (CNS) symptom, and a skin rash with high-grade fever preceded the CNS symptoms in 9 patients. Magnetic resonance imaging of the brain showed an abnormal increased T2 signal in the hypothalamus of 5 patients. Eight patients were treated with ganciclovir, and an improvement of CNS symptoms was obtained in 3 patients; 3 patients treated with acyclovir showed no improvement. Improvement in the meningoencephalitis seemed less frequent in patients with abnormal findings in the hypothalamus than in those without such findings. Because the symptoms of HHV-6 meningoencephalitis mimicked those of cyclosporine- or tacrolimus-induced encephalopathy, the drugs were withdrawn at the onset of CNS symptoms in 10 patients, resulting in the development of grade IV graft-versus-host disease (GVHD) in 5 patients. Three patients died of HHV-6 meningoencephalitis, and 6 died of other causes, including GVHD. In conclusion, HHV-6 meningoencephalitis is a rare but potentially life-threatening complication in patients who undergo allogeneic HSCT. Careful assessment of the clinical findings and the brain may allow early and precise diagnosis of HHV-6 meningoencephalitis and contribute to improving its prognosis.

Original languageEnglish
Pages (from-to)432-437
Number of pages6
JournalInternational Journal of Hematology
Volume84
Issue number5
DOIs
Publication statusPublished - 2006 Dec

Fingerprint

Human Herpesvirus 6
Meningoencephalitis
Hematopoietic Stem Cells
Transplants
Central Nervous System
Hematopoietic Stem Cell Transplantation
Graft vs Host Disease
Hypothalamus
Transplant Recipients
Confusion
Ganciclovir
Acyclovir
Brain
Brain Diseases
Tacrolimus
Exanthema
Cyclosporine
Siblings
Early Diagnosis

Keywords

  • Allogeneic hematopoietic stem cell transplantation
  • Graft-versus-host disease
  • Human herpesvirus 6
  • Meningoencephalitis
  • Neurologic symptoms

ASJC Scopus subject areas

  • Hematology

Cite this

Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients. / Fujimaki, Katsumichi; Mori, Takehiko; Kida, Aiko; Tanaka, Masatsugu; Kawai, Nobutaka; Matsushima, Takafumi; Kishi, Kenji; Fujisawa, Shin; Sakura, Tohru; Yokota, Akira; Kanda, Yoshinobu; Taguchi, Jun; Akiyama, Hideki; Kanamori, Heiwa; Maruta, Atsuo; Okamoto, Shinichiro; Sakamaki, Hisashi.

In: International Journal of Hematology, Vol. 84, No. 5, 12.2006, p. 432-437.

Research output: Contribution to journalArticle

Fujimaki, K, Mori, T, Kida, A, Tanaka, M, Kawai, N, Matsushima, T, Kishi, K, Fujisawa, S, Sakura, T, Yokota, A, Kanda, Y, Taguchi, J, Akiyama, H, Kanamori, H, Maruta, A, Okamoto, S & Sakamaki, H 2006, 'Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients', International Journal of Hematology, vol. 84, no. 5, pp. 432-437. https://doi.org/10.1532/IJH97.06072
Fujimaki, Katsumichi ; Mori, Takehiko ; Kida, Aiko ; Tanaka, Masatsugu ; Kawai, Nobutaka ; Matsushima, Takafumi ; Kishi, Kenji ; Fujisawa, Shin ; Sakura, Tohru ; Yokota, Akira ; Kanda, Yoshinobu ; Taguchi, Jun ; Akiyama, Hideki ; Kanamori, Heiwa ; Maruta, Atsuo ; Okamoto, Shinichiro ; Sakamaki, Hisashi. / Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients. In: International Journal of Hematology. 2006 ; Vol. 84, No. 5. pp. 432-437.
@article{5af5b87b301e4c848841b105cfe5c2fc,
title = "Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients",
abstract = "We retrospectively investigated the clinical characteristics of human herpesvirus 6 (HHV-6) meningoencephalitis within 100 days after allogeneic hematopoietic stem cell transplantation (HSCT). Of 1148 patients who received transplants between January 1999 and December 2003, 11 patients (0.96{\%}) with HHV-6 meningoencephalitis were identified. Ten of 11 recipients received hematopoietic stem cells from donors other than HLA-identical siblings. Confusion was the most frequent central nervous system (CNS) symptom, and a skin rash with high-grade fever preceded the CNS symptoms in 9 patients. Magnetic resonance imaging of the brain showed an abnormal increased T2 signal in the hypothalamus of 5 patients. Eight patients were treated with ganciclovir, and an improvement of CNS symptoms was obtained in 3 patients; 3 patients treated with acyclovir showed no improvement. Improvement in the meningoencephalitis seemed less frequent in patients with abnormal findings in the hypothalamus than in those without such findings. Because the symptoms of HHV-6 meningoencephalitis mimicked those of cyclosporine- or tacrolimus-induced encephalopathy, the drugs were withdrawn at the onset of CNS symptoms in 10 patients, resulting in the development of grade IV graft-versus-host disease (GVHD) in 5 patients. Three patients died of HHV-6 meningoencephalitis, and 6 died of other causes, including GVHD. In conclusion, HHV-6 meningoencephalitis is a rare but potentially life-threatening complication in patients who undergo allogeneic HSCT. Careful assessment of the clinical findings and the brain may allow early and precise diagnosis of HHV-6 meningoencephalitis and contribute to improving its prognosis.",
keywords = "Allogeneic hematopoietic stem cell transplantation, Graft-versus-host disease, Human herpesvirus 6, Meningoencephalitis, Neurologic symptoms",
author = "Katsumichi Fujimaki and Takehiko Mori and Aiko Kida and Masatsugu Tanaka and Nobutaka Kawai and Takafumi Matsushima and Kenji Kishi and Shin Fujisawa and Tohru Sakura and Akira Yokota and Yoshinobu Kanda and Jun Taguchi and Hideki Akiyama and Heiwa Kanamori and Atsuo Maruta and Shinichiro Okamoto and Hisashi Sakamaki",
year = "2006",
month = "12",
doi = "10.1532/IJH97.06072",
language = "English",
volume = "84",
pages = "432--437",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "5",

}

TY - JOUR

T1 - Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients

AU - Fujimaki, Katsumichi

AU - Mori, Takehiko

AU - Kida, Aiko

AU - Tanaka, Masatsugu

AU - Kawai, Nobutaka

AU - Matsushima, Takafumi

AU - Kishi, Kenji

AU - Fujisawa, Shin

AU - Sakura, Tohru

AU - Yokota, Akira

AU - Kanda, Yoshinobu

AU - Taguchi, Jun

AU - Akiyama, Hideki

AU - Kanamori, Heiwa

AU - Maruta, Atsuo

AU - Okamoto, Shinichiro

AU - Sakamaki, Hisashi

PY - 2006/12

Y1 - 2006/12

N2 - We retrospectively investigated the clinical characteristics of human herpesvirus 6 (HHV-6) meningoencephalitis within 100 days after allogeneic hematopoietic stem cell transplantation (HSCT). Of 1148 patients who received transplants between January 1999 and December 2003, 11 patients (0.96%) with HHV-6 meningoencephalitis were identified. Ten of 11 recipients received hematopoietic stem cells from donors other than HLA-identical siblings. Confusion was the most frequent central nervous system (CNS) symptom, and a skin rash with high-grade fever preceded the CNS symptoms in 9 patients. Magnetic resonance imaging of the brain showed an abnormal increased T2 signal in the hypothalamus of 5 patients. Eight patients were treated with ganciclovir, and an improvement of CNS symptoms was obtained in 3 patients; 3 patients treated with acyclovir showed no improvement. Improvement in the meningoencephalitis seemed less frequent in patients with abnormal findings in the hypothalamus than in those without such findings. Because the symptoms of HHV-6 meningoencephalitis mimicked those of cyclosporine- or tacrolimus-induced encephalopathy, the drugs were withdrawn at the onset of CNS symptoms in 10 patients, resulting in the development of grade IV graft-versus-host disease (GVHD) in 5 patients. Three patients died of HHV-6 meningoencephalitis, and 6 died of other causes, including GVHD. In conclusion, HHV-6 meningoencephalitis is a rare but potentially life-threatening complication in patients who undergo allogeneic HSCT. Careful assessment of the clinical findings and the brain may allow early and precise diagnosis of HHV-6 meningoencephalitis and contribute to improving its prognosis.

AB - We retrospectively investigated the clinical characteristics of human herpesvirus 6 (HHV-6) meningoencephalitis within 100 days after allogeneic hematopoietic stem cell transplantation (HSCT). Of 1148 patients who received transplants between January 1999 and December 2003, 11 patients (0.96%) with HHV-6 meningoencephalitis were identified. Ten of 11 recipients received hematopoietic stem cells from donors other than HLA-identical siblings. Confusion was the most frequent central nervous system (CNS) symptom, and a skin rash with high-grade fever preceded the CNS symptoms in 9 patients. Magnetic resonance imaging of the brain showed an abnormal increased T2 signal in the hypothalamus of 5 patients. Eight patients were treated with ganciclovir, and an improvement of CNS symptoms was obtained in 3 patients; 3 patients treated with acyclovir showed no improvement. Improvement in the meningoencephalitis seemed less frequent in patients with abnormal findings in the hypothalamus than in those without such findings. Because the symptoms of HHV-6 meningoencephalitis mimicked those of cyclosporine- or tacrolimus-induced encephalopathy, the drugs were withdrawn at the onset of CNS symptoms in 10 patients, resulting in the development of grade IV graft-versus-host disease (GVHD) in 5 patients. Three patients died of HHV-6 meningoencephalitis, and 6 died of other causes, including GVHD. In conclusion, HHV-6 meningoencephalitis is a rare but potentially life-threatening complication in patients who undergo allogeneic HSCT. Careful assessment of the clinical findings and the brain may allow early and precise diagnosis of HHV-6 meningoencephalitis and contribute to improving its prognosis.

KW - Allogeneic hematopoietic stem cell transplantation

KW - Graft-versus-host disease

KW - Human herpesvirus 6

KW - Meningoencephalitis

KW - Neurologic symptoms

UR - http://www.scopus.com/inward/record.url?scp=33846022700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846022700&partnerID=8YFLogxK

U2 - 10.1532/IJH97.06072

DO - 10.1532/IJH97.06072

M3 - Article

VL - 84

SP - 432

EP - 437

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 5

ER -